Strata EXPress™: A Study Using StrataEXP™ to Identify RNA-Expression Biomarkers in Advanced Cancer Patients

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

NCT03553550 ·Status: TERMINATED

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

NCT02853097 ·Status: TERMINATED

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

NCT05347797 ·Status: COMPLETED ·Phase: NA

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

NCT05360225 ·Status: COMPLETED

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

NCT05833360 ·Status: RECRUITING

PRecision Oncology Evidence Development in Cancer Treatment - Liquid

NCT05057234 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

NCT00897650 ·Status: COMPLETED

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

NCT05530759 ·Status: RECRUITING

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

NCT02026960 ·Status: TERMINATED ·Phase: NA

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

NCT02470819 ·Status: WITHDRAWN ·Phase: NA

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

NCT05837884 ·Status: RECRUITING

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

NCT04976803 ·Status: COMPLETED

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198 ·Status: COMPLETED

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

NCT03071809 ·Status: TERMINATED

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

NCT03108885 ·Status: TERMINATED

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

NCT03466034 ·Status: TERMINATED

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

NCT00907699 ·Status: WITHDRAWN

Recurrence Monitoring in NSCLC Using Circulating Tumor DNA

NCT03878537 ·Status: UNKNOWN

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

NCT03869814 ·Status: RECRUITING

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

NCT01553448 ·Status: COMPLETED

Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

NCT03265496 ·Status: TERMINATED ·Phase: NA

Pan-tumor MRD Study

NCT06605404 ·Status: RECRUITING

Evaluating a New Gonadotoxic Risk Stratification System

NCT05052632 ·Status: WITHDRAWN

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

NCT05356585 ·Status: WITHDRAWN

Nuclear Matrix and Cancer: Proteomic and Genomic Analyses Using Microarray in Cells Obtained Via Thoracocentesis

NCT01284777 ·Status: COMPLETED